{"anticipatedPostingDate":"2010-06","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Overall response (complete remission plus partial remission) rate at 3 months, as defined by International Working Group for non-Hodgkin lymphoma and NCI Working Group guidelines for chronic lymphocytic leukemia","groups":[{"description":"Patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with 1 dose donor natural killer cells infusion, 4 doses rituximab, 6 doses aldesleukin and 5 doses fludarabine and 1 dose cyclosphosphamide.","id":"OG000","title":"Patients Treated With Natural Killer Cells"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"3 Months","title":"Number of Patients With Overall Response","type":"SECONDARY","unitOfMeasure":"Participants"}